Nitrofurantoin Pulmonary Toxicity: Neglected Threat

Author(s): Emilia Hardak, Gidon Berger, Norberto Krivoy, Anna Solomonov, Mordechai Yigla

Journal Name: Current Drug Safety

Volume 5 , Issue 2 , 2010

Become EABM
Become Reviewer


Nitrofurantoin lung toxicity was diagnosed among ten patients receiving 50 mg/day to prevent recurrent urinary tract infection. In six patients a symptomatic period of 3-36 months preceded the diagnosis. All but one patient, with irreversible lung injury at presentation recovered completely, five after drug discontinuation and four after steroids therapy. Large amount of data regarding unexpected, sometimes severe pulmonary toxicity during nitrofurantoin therapy should maintain a high index of suspicion for the drug usage among patients with non-resolving pulmonary symptoms. Alternatively, the use of other antimicrobial agents with a better risk-to-benefit ratio should be considered.

Keywords: Lung, nitrofurantoin, toxicity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [125 - 128]
Pages: 4
DOI: 10.2174/157488610790936169
Price: $65

Article Metrics

PDF: 17